The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, open-label, phase 2 study of odetiglucan (IMPRIME PGG) and pembrolizumab in patients with metastatic breast cancer (mBCA) who have progressed through prior hormonal therapy.
 
Alison Stopeck
Honoraria - Amgen; Beigene; Rhenium/Oncotest
Consulting or Advisory Role - AstraZeneca; Athenex; Biotheranostics; Boehringer Ingelheim; Exact Sciences; Macrogenics; Regeneron
Speakers' Bureau - Exact Sciences
Research Funding - Amgen (Inst); AstraZeneca (Inst); Genomic Health (Inst); Seagen (Inst)
Expert Testimony - Sandoz-Novartis
 
Michele Anne Gargano
Employment - HiberCell
Stock and Other Ownership Interests - Biothera; HiberCell
 
Nick Niles
Employment - Bellerophon Theraeutics; HiberCell
Stock and Other Ownership Interests - Bellerophon Theraeutics; HiberCell
 
Blaine Rathmann
Employment - HiberCell
Stock and Other Ownership Interests - HiberCell
 
Michael Jon Chisamore
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Nandita Bose
Employment - HiberCell
Stock and Other Ownership Interests - Biothera; HiberCell
Patents, Royalties, Other Intellectual Property - HiberCell
 
Jose Luis Iglesias
Consulting or Advisory Role - Carina; Epsilogen; HiberCell; Panavance Therapeutics; Senti Biosciences